Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial

A personalized cancer vaccine approach combined with immunotherapy shows promise for hard-to-treat lung cancers.

What the study was

Journal

Nat Commun

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.